Every patient deserves an answer. So we created a new way to find one.
Every patient deserves an answer. So we created a new way to find one.
About First Ascent Biomedical
First Ascent Biomedical is a biotech start-up founded in 2018 with a mission to transform medical oncology through highly individualized, prospective treatment planning technologies that improve survival and advance science.
We uniquely combine drug sensitivity testing, genomics, and machine learning so your doctor has the clearest evidence of what works for you before your next treatment.
Our Mission
Inspired by our own journeys as parents, survivors, and advocates, we are on a mission to bring hope and real answers to those facing a cancer diagnosis, or relapse—redefining cancer treatment, one patient at a time.
“1 in 3 cancer patients will lose the fight. My son was one of those three.” Jim Foote, CEO
Our Co-Founder’s Story
My son Trey was an amazing kid. He loved everything a 16-year-old should love. Trey was diagnosed with bone cancer, and he fought hard through surgery and chemo.
When it came back, I was shocked when the doctors said, “We’re sorry, we’ve given it the best we’ve got. We’re out of options. What would you like to do?”
“What would I like to do?” I thought this was a medical problem. I’m a technology executive. I did my research. I learned that Trey’s treatment protocol hadn’t changed in 25 years. I learned there were no promising treatments available. I learned the hard way that when your cancer comes back, there are often few effective options left.
I couldn’t solve this problem to save my son. That’s why we started First Ascent Biomedical.
When someone you love is facing cancer, “Will this work?” is the only question that matters. Our data give you and your doctor the clearest possible answer.
